Dr Tarun Dua – World Health OrganizationEpidemiological Adventures in Encephalitis
Dr Jim Sejvar – Centers for Disease Control and Prevention (CDC), USA
Invited Guest Lectures
Paediatric Autoimmune Encephalitides
Dr Sukhvir Wright – Aston University, UK
The Role of Dexamethasone in Herpes Encephalitis; a Crystal Clear Answer
Professor Tom Solomon CBE – The Pandemic Institute and The University of Liverpool, UK
Lectures
Comparative characteristics in anti-LGI1 and anti-CASPR2 encephalitis
Dr Sophia Michael & Dr Christine Strippel, Oxford Autoimmune Neurology Group, UK
Auto-antibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ~40% of patients
Mr Adrian Gervais – Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, France
ES funded research: Host mRNA signature in scrub typhus meningoencephalitis
Dr Tina Damodar – National Institute of Mental Health and Neurosciences India
NMDA receptor encephalitis and multiple sclerosis overlap syndrome – clinical findings and MRI characteristics
Dr Joseph Kuchling – Charité – Universitätsmedizin Berlin, Germany
Cognitive outcomes and associated biomarkers and neuroimaging in COVID-19 encephalitis: analysis of the UK COVID-19 CNS
Dr Greta Wood – University of Liverpool, UK
Highly differentiated LGI1/CASPR2-reactive plasmablasts characterise CSF of encephalitis patients and provide a potential treatment target
Dr Jakob Theorell – Karolinska Institutet, Stockholm, Sweden
Recovery trajectories after severe encephalitis: a prospective multicentre cohort study
Prof Romain Sonneville – Claude Bernard Bichat Hospital, France
Functional neurological disorder in the long-term management of adults with autoimmune encephalitis and related disorders
Dr Nicole Lichtblau – King’s College Hospital London, UK
Exploring barriers and enablers to vaccine confidence among ethnically diverse communities in Liverpool – Qualitative findings from the MSD Liverpool Vaccine Confidence Project
Ms Charlotte O’Halloran – MSD, UK
The epidemiology and possible aetiology of encephalitis lethargica in a large historical cohort
Dr Jonathan Rogers – University College London, UK
Debate
“This house believes that too much time and money is being spent identifying new antibodies in autoimmune encephalitis.”
Chair: Dr Thomas Pollak – King’s College London, UK
For: Dr Sophie Binks – Oxford Autoimmune Neurology Group, UK
Against: Prof Dr Harald Prüss – Charité Universitätsmedizin Berlin, Germany
